 |
 |
 |
Country |
|
|
Pharmaceuticals in Canada
Publication Date December 2007
Publisher Datamonitor
Product Type Strategic Report
Pages 35
ISBN Number not applicable
Product Code DAT843
|
|
|
Summary
The Pharmaceuticals in Canada industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
Scope
- Contains an executive summary and data on value, volume and/or segmentation
- Provides textual analysis of the industry's recent performance and future prospects
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Includes a five-year forecast of the industry
- The leading companies are profiled with supporting key financial metrics
- Supported by the key macroeconomic and demographic data affecting the market
Highlights
- Detailed information is included on market size, measured by value and/or volume
- Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
- Market shares are covered by manufacturer or brand
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Market Definition
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates.
For the purpose of this report the Americas comprise Brazil, Canada, Mexico and the US.
|
Content
- Executive Summary
- Chapter 1 Market Overview
- 1.1 Market Definition
- 1.2 Research Highlights
- 1.3 Market Analysis
- Chapter 2 Market Value
- Chapter 3 Market Segmentation I
- Chapter 4 Market Segmentation Ii
- Chapter 5 Market Share
- Chapter 6 Five Forces Analysis
- 6.1 Summary
- 6.2 Buyer Power
- 6.3 Supplier Power
- 6.4 New Entrants
- 6.5 Substitutes
- 6.6 Rivalry
- Chapter 7 Leading Companies
- 7.1 Pfizer Inc
- 7.2 Astrazeneca Plc
- 7.3 Johnson & Johnson
- 7.4 Apotex, Inc.
- Chapter 8 Market Forecasts
- 8.1 Market Value Forecast
- Chapter 9 Macroeconomic Indicators
- Chapter 10 Appendix
- 10.1 Methodology
- 10.2 Industry Associations
- 10.3 Related Datamonitor Research
- List Of Tables
- Table 1: Canada Pharmaceuticals Market Value: $ Million, 2003-2007
- Table 2: Canada Pharmaceuticals Market Segmentation I: % Share, By Value, 2007
- Table 3: Canada Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2007
- Table 4: Canada Pharmaceuticals Market Share: % Share, By Value, 2007
- Table 5: Key Facts: Pfizer Inc
- Table 6: Key Financials: Pfizer Inc
- Table 7: Key Facts: Astrazeneca Plc
- Table 8: Key Financials: Astrazeneca Plc
- Table 9: Key Facts: Johnson & Johnson
- Table 10: Key Financials: Johnson & Johnson
- Table 11: Key Facts: Apotex, Inc.
- Table 12: Canada Pharmaceuticals Market Value Forecast: $ Million, 2007-2012
- Table 13: Canada Size Of Population (Million) , 2003-2007
- Table 14: Canada Gdp (Constant 2000 Prices, $ Billion), 2003-2007
- Table 15: Canada Inflation, 2003-2007
- Table 16: Canada Exchange Rate, 2003
|
|
|